These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 9003873)

  • 41. Effects of cisapride on parameters of oesophageal motility and on the prolonged intraoesophageal pH test in infants with gastro-oesophageal reflux disease.
    Cucchiara S; Staiano A; Boccieri A; De Stefano M; Capozzi C; Manzi G; Camerlingo F; Paone FM
    Gut; 1990 Jan; 31(1):21-5. PubMed ID: 2180792
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Cisapride: the problem of the heart.
    Premji SS; Paes B
    Neonatal Netw; 1999 Oct; 18(7):21-5. PubMed ID: 10808885
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Cisapride marketed for use in gastroesophageal reflux disease.
    Clin Pharm; 1993 Dec; 12(12):876, 879. PubMed ID: 8137603
    [No Abstract]   [Full Text] [Related]  

  • 44. Cisapride for gastro-oesophageal reflux and peptic oesophagitis.
    Cucchiara S; Staiano A; Capozzi C; Di Lorenzo C; Boccieri A; Auricchio S
    Arch Dis Child; 1987 May; 62(5):454-7. PubMed ID: 3300570
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A comparison of the pharmacokinetics of two dosing regimens of cisapride and their effects on corrected QT interval in premature infants.
    Cools F; Benatar A; Bruneel E; Theyskens C; Bougatef A; Casteels A; Vandenplas Y
    Eur J Clin Pharmacol; 2003 May; 59(1):17-22. PubMed ID: 12682804
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Cisapride.
    Molinari F; Farrington E
    Pediatr Nurs; 1994; 20(2):202-3. PubMed ID: 8159508
    [No Abstract]   [Full Text] [Related]  

  • 47. Cisapride decreases gastroesophageal reflux in preterm infants.
    Ariagno RL; Kikkert MA; Mirmiran M; Conrad C; Baldwin RB
    Pediatrics; 2001 Apr; 107(4):E58. PubMed ID: 11335779
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Absence of effect of cisapride on heart rate].
    Chéron G; Bernard F; Sallenave JR; Dupont C
    Presse Med; 1991 Jun; 20(24):1138. PubMed ID: 1830151
    [No Abstract]   [Full Text] [Related]  

  • 49. [Results of the treatment of gastroesophageal reflux and peptic esophagitis using cisapride].
    Carrasco Gandía S; Lama Moré R; Prieto Bozano G; Polanco Allue I
    An Esp Pediatr; 1990 Jun; 32(6):485-8. PubMed ID: 2221622
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Cisapride 20 mg b.i.d. provides symptomatic relief of heartburn and related symptoms of chronic mild to moderate gastroesophageal reflux disease. CIS-USA-52 Investigator Group.
    Castell DO; Sigmund C; Patterson D; Lambert R; Hasner D; Clyde C; Zeldis JB
    Am J Gastroenterol; 1998 Apr; 93(4):547-52. PubMed ID: 9576446
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Domperidone-induced QT prolongation: add another drug to the list.
    Collins KK; Sondheimer JM
    J Pediatr; 2008 Nov; 153(5):596-8. PubMed ID: 18940349
    [No Abstract]   [Full Text] [Related]  

  • 52. Cisapride restores the decreased lower oesophageal sphincter pressure in reflux patients.
    Ceccatelli P; Janssens J; Vantrappen G; Cucchiara S
    Gut; 1988 May; 29(5):631-5. PubMed ID: 3294123
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Effect of cisapride on corrected QT interval in neonates.
    Khorana M; Chankajorn W; Kanjanapattanakul W; Kirawittaya T; Horpaopan S; Chotigeat U; Sangtawesin W
    J Med Assoc Thai; 2003 Aug; 86 Suppl 3():S590-5. PubMed ID: 14700153
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Influence of cisapride on food-stimulated gastro-oesophageal reflux: a radiological study.
    Gelineck J; Aksglade K; Funch-Jensen P; Thommesen P
    Rontgenblatter; 1990 Aug; 43(8):352-4. PubMed ID: 2204995
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Gastroesophageal reflux (GER)].
    Guala A; Licardi G; Mannarino S; Ghini T
    Pediatr Med Chir; 1995; 17(4):383-4. PubMed ID: 7491340
    [No Abstract]   [Full Text] [Related]  

  • 56. [A new granular effervescent 10-mg formulation of cisapride in the treatment of gastroesophageal reflux].
    Grossi L; Di Felice F; Marzio L
    Clin Ter; 1993 Feb; 142(2):127-33. PubMed ID: 8472526
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Spontaneous adverse event reports of serious ventricular arrhythmias, QT prolongation, syncope, and sudden death in patients treated with cisapride.
    Barbey JT; Lazzara R; Zipes DP
    J Cardiovasc Pharmacol Ther; 2002 Apr; 7(2):65-76. PubMed ID: 12075394
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Domperidone versus cisapride in the treatment of infant regurgitation and increased acid gastro-oesophageal reflux: a pilot study.
    Hegar B; Alatas S; Advani N; Firmansyah A; Vandenplas Y
    Acta Paediatr; 2009 Apr; 98(4):750-5. PubMed ID: 19076984
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Effect of cisapride and cimetidine on 24-hour intraesophageal pH monitoring in patients with gastroesophageal reflux disease.
    Chojnacki J; Tkaczewski W; Wichan P; Grzegorczyk K; Klupińska G
    Mater Med Pol; 1992; 24(3):196-8. PubMed ID: 1307654
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Effect of cisapride on rate-corrected QT intervals in children on peritoneal dialysis.
    Marx M; Kitzmueller E; Pichler A; Arbeiter K; Aufricht C
    Pediatr Nephrol; 2002 Aug; 17(8):652-5. PubMed ID: 12185476
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.